[Correspondence] Ocular gene therapy for neovascular AMD: a new era?

We read with great interest the study by Jeffrey S Heier and colleagues (July 1, p 50)1 on the beneficial effects of an intravitreal injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration (AMD). Despite the original findings, there are methodological concerns that need to be further addressed.

Source: LANCET - November 10, 2017 Category: General Medicine Authors: Irini P Chatziralli, Theodoros N Sergentanis Tags: Correspondence Source Type: research